Survival prediction based on compound covariate under cox proportional hazard models by Emura, Takeshi et al.
MPRA
Munich Personal RePEc Archive
Survival prediction based on compound
covariate under cox proportional hazard
models
Takeshi Emura and Yi-Hau Chen and Hsuan-Yu Chen
Institute of Statistical Science, Academia Sinica, Taiwan
2012
Online at http://mpra.ub.uni-muenchen.de/41149/
MPRA Paper No. 41149, posted 14. January 2013 18:24 UTC
Survival Prediction Based on Compound Covariate under
Cox Proportional Hazard Models
Takeshi Emura, Yi-Hau Chen*, Hsuan-Yu Chen
Institute of Statistical Science, Academia Sinica, Nankang, Taipei, Taiwan
Abstract
Survival prediction from a large number of covariates is a current focus of statistical and medical research. In this paper, we
study a methodology known as the compound covariate prediction performed under univariate Cox proportional hazard
models. We demonstrate via simulations and real data analysis that the compound covariate method generally competes
well with ridge regression and Lasso methods, both already well-studied methods for predicting survival outcomes with a
large number of covariates. Furthermore, we develop a refinement of the compound covariate method by incorporating
likelihood information from multivariate Cox models. The new proposal is an adaptive method that borrows information
contained in both the univariate and multivariate Cox regression estimators. We show that the new proposal has a
theoretical justification from a statistical large sample theory and is naturally interpreted as a shrinkage-type estimator, a
popular class of estimators in statistical literature. Two datasets, the primary biliary cirrhosis of the liver data and the non-
small-cell lung cancer data, are used for illustration. The proposed method is implemented in R package ‘‘compound.Cox’’
available in CRAN at http://cran.r-project.org/.
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Introduction
Predicting survival outcomes in the presence of a large number
of covariates has received much attention in the recent decade.
The prominent motivation for this comes from predictions of
patient survival based on gene expression profiles. For example,
gene expression profiles have been used to improve the prediction
power of the clinical outcomes for breast cancer patients [1,2,3,4]
and lung cancer patients [5,6,7]. Utilizing gene profiles, van’t Veer
et al. [3] provided a criterion for selecting patients who would
benefit from adjuvant therapy, which reduces patients’ risks over
traditional guidelines based on histological and clinical character-
istics. Chen et al. [6] examined 672 gene profiles for non-small-cell
lung cancer patients to identify a gene signature closely related to
survival. Even without gene expression profiles, patients data often
include a large number of clinical, serologic and histologic
characteristics. Hence, it is of interest to efficiently utilize a large
number of covariates to predict clinical outcomes.
A statistical challenge arises if the number of covariates p is large
relative to the number of individuals n. The problem becomes
further involved with the presence of censoring. The standard
regression techniques in the presence of censoring, including the
Cox regression analysis [8], fail to provide a satisfactory result.
Two types of strategies have been commonly used to perform
survival prediction with a panel of covariate data. The first strategy
is to select subsets of covariates by univariate survival analyses
[1,6] or various clustering algorithms [9]. Then, one can apply
standard methods for prediction. The second strategy for resolving
high-dimensionality utilizes some penalizing schemes on the Cox
regression analysis. In particular, the Lasso [10,11,12] and ridge
regression [13,14] are obtained by penalizing the Cox’s partial
likelihood function with L1 and L2 penalties, respectively. The two
types of penalization yield p regression coefficients that are shrunk
toward zero.
In this paper, we study a methodology known as the compound
covariate prediction. The compound covariate prediction method
is based on a linear combination of the univariate Cox regression
estimates and has been previously used in medical studies with
microarrays [5,6,15,16]. However, few papers have investigated its
statistical properties and comparative performance with other
methods. For instance, recent comparative studies of Bovelstad
et al. [17], van Wieringen et al. [18], and Bovelstad and Borgan
[19] have all demonstrated that ridge regression has the overall
best predictive performance among many well-known survival
prediction methods, including univariate selection, forward
selection, Lasso, principal components, supervised principal
components, partial least squares, random forests, etc., but
excluding the compound covariate method. Additionally, the
compound covariate prediction can be a powerful method even for
more traditional survival data that may not involve microarrays, as
we will see in the analysis of the primary biliary cirrhosis of the
liver data. Hence, the first objective of this paper is to study the
statistical properties and comparative performance of the com-
pound covariate method, in order to fill a gap in the current
literature and highlight the competitive performance of the
compound covariate method with other methods.
The second objective of this paper is to develop a new statistical
methodology that refines the compound covariate method. This
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methodology aims to incorporate the combined predictive
information of covariates into a compound covariate predictor
by forming a mixture of multivariate and univariate Cox partial
likelihoods. Such a method is shown to have a theoretical
justification under a statistical large sample theory, and is naturally
interpreted as a shrinkage-type estimator, a popular class of
estimators in statistical literature.
We also compare the compound covariate and the newly
proposed methods with the benchmark methods of ridge
regression and Lasso analyses via Monte Carlo simulations and
real data analysis. The primary biliary cirrhosis of the liver data
and the non-small-cell lung cancer data are used for illustration.
All the numerical performances of the methods are evaluated via
cross-validated schemes.
Methods
Existing Methods
To facilitate the subsequent discussions, we shall introduce
existing methods for predicting survival outcomes. Let
xi~( xi1, :::, xip )’ be a p-dimensional vector of covariates from
individual i. We observe ( ti, di, xi ), where ti is either survival or
censoring time, and di satisfies di~1 if ti is survival time and di~0
otherwise. In the Cox regression [8], the hazard function for
individual i is modeled as
h(t D xi)~ h0(t) exp (b’xi), ð1Þ
where b~( b1, :::, bp )’ are unknown coefficients and h0 is an
unknown baseline hazard function. Let Ri~f ‘ : t‘§ti g be the
risk set that contains individuals who still survive at time ti. The
regression estimate is obtained by maximizing the partial
likelihood given as
L1n(b)~ P
n
i~1
exp (b’xi)P
‘[Ri
exp (b’x‘)
 !di
: ð2Þ
When the dimension p is large relative to the sample size n, the
maximum of L1n(b) is not uniquely determined.
An intuitive and widely used approach to resolve high-
dimensionality is based on the univariate selection. As the initial
step, a Cox regression based on the univariate model
h(tDxij)~h0j(t) exp (bjxij), or a log-rank test between the high
and low covariate groups, is performed for each j~1, :::, p, one-
by-one. Then one picks out a subset of covariates that have low P-
values from the univariate analysis (e.g., Jenssen et al. [1]). The top
t covariates with lowest P-values are then included in a
multivariate Cox regression, where the number t can be
determined by cross-validation and/or biological consideration.
Although the univariate selection is easy to implement, the process
of selecting covariates is solely based on the marginal significance,
and hence there is no guarantee that the resultant multivariate
model achieves an accurate prediction.
A more sophisticated approach to resolve high-dimensionality is
to utilize the L1 penalized partial likelihood
logL1n(b){ l
Xp
j~1
Dbj D, ð3Þ
or the L2 penalized partial likelihood
logL1n(b){ (l=2)
Xp
j~1
b2j , ð4Þ
where lw0 is the tuning (shrinkage) parameter. The two
methods shrink the coefficients to zero. The estimator resulting
from equation (3) is called the Lasso [10,11,12]. An important
feature of the Lasso is that many coefficients will be estimated
exactly as zero. This implies that the Lasso can be used as a
variable selection tool for a parsimonious prediction model. On
the other hand, the estimation based on equation (4) is called ridge
regression [13,14], which results in p non-zero coefficient
estimates. Therefore, unlike the Lasso, the prediction model from
ridge regression uses all the covariates. The tuning parameter l
can be obtained empirically by a cross-validation criterion
proposed by Verweij and van Houwelingen [20]. Both the Lasso
and ridge regression methods are implemented through the R
package ‘‘penalized’’ [21].
There are a number of other methods available to handle high-
dimensional covariates, including the forward stepwise selection,
principal components, supervised principal components, Lasso
principal components, partial least squares regression, and tree-
based methods, etc.; refer to Witten and Tibshirani [22] for an
excellent summary. Bovelstad et al. [17], van Wieringen et al. [18],
and Bovelstad and Borgan [19] systematically compared these
methods and concluded that ridge regression has the best overall
performance for survival prediction. However, the compound
covariate method has not been included in these comparative
studies.
Compound Covariate Prediction
For a future subject with a covariate vector x~( x1, . . . , xp )’,
the survival prediction can be made by the prognostic index (PI)
defined as w’x, where w~( w1, :::, wp )’ is a vector of weights.
Typically, w is determined by the dataset
f (ti, di, xi); i~1, . . . , n g and is chosen so that w’x is associated
with the subject’s survival. When p is small relative to n, the
multivariate Cox’s partial likelihood estimator maximizing equa-
tion (2) can be used for w. Alternatively, one can set wj to be the
estimated regression coefficient for bj by fitting the univariate Cox
model h(tDxij)~h0j(t) exp (bjxij), for each j~1, :::, p, one-by-one.
This prediction method is called the compound covariate prediction [23]
and it is applicable even when p. n. The method has been shown
to be useful in medical studies with microarrays as a convenient
and powerful tool for survival prediction [5,6,15,16]. Note that
even when p, n, where a multivariate Cox regression is
applicable, the compound covariate prediction may further
improve predictive power. We will demonstrate this aspect
through the analysis of the primary biliary cirrhosis of the liver
data.
Refinement of the Compound Covariate Method
The construction of the compound covariate predictor is purely
based on the univariate (marginal) likelihood functions. This
methodology may be further improved by incorporating the
combined predictive information of covariates into the compound
covariate predictor. Here we propose a mixture of the multivariate
and univariate (marginal) likelihoods. For each covariate
j (~1, :::, p), the univariate Cox regression estimator for bj is
obtained by maximizing
Survival Prediction
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L0n, j(bj)~ P
n
i~1
exp (bjxij)P
‘[Ri
exp (bjx‘j)
 !di
: ð5Þ
We combine the likelihoods in equation (5) over all
j (~1, :::, p), namely,
L0n(b)~ P
p
j~1
L0n,j(bj):
Note that the maximizer of L0n(b) is found as the set of the p
univariate Cox regression estimates even when pwn, and hence
L0n(b) adapts easily to high-dimensionality. On the other hand,
L1n(b) does not have a unique solution when pwn, although it
potentially contains the combined predictive information of
covariates. To gain an adequate compromise between L1n(b) and
L0n(b), we consider a mixture log-likelihood
‘an(b)~ a logL
1
n(b)z (1{ a) logL
0
n(b), ð6Þ
where a[½0, 1 is the tuning (shrinkage) parameter. For a fixed
a[½0, 1), the maximizer of equation (6) is denoted by b^(a). We will
call b^(a) the compound shrinkage estimator, and b^(0) the compound covariate
estimator, which is a special case of b^(a) at a~0. The compound
shrinkage predictor b^(a)’x can thus be viewed as a generalization
of the compound covariate predictor b^(0)’x, with a larger a
leading to a larger degree of multivariate likelihood information
(Figure 1). It will be seen that the value of a can be empirically
estimated by cross-validation.
The idea of the compound shrinkage as a mixture of the
multivariate and univariate likelihoods is closely related to a
‘‘shrinkage’’ scheme in statistical literature. This has the effect of
reducing (shrinking) the infinite dimensional solution space of the
multivariate likelihood equations toward the unique nearest point
of b^(0) as demonstrated in Figure 1. Here, a=0 stands for the
maximal shrinkage and a=1 for no shrinkage.
Choosing the Shrinkage Parameter by Cross Validation
The shrinkage parameter a in equation (6) should be chosen so
that the predictive power of b^(a)’x is maximized. For this purpose,
we adopt a cross-validation criterion based on partial likelihood
[20]. To perform a K-fold cross validation, we first divide n
individuals into K groups of about equal sample sizes, and label
them as =k for k~1, :::,K . The maximizer of equation (6) based
on all individuals not in =k is calculated and denoted by b^({k)(a).
Repeat this process for k~1, :::,K , and the cross-validation
criterion is
CV (a)~
XK
k~1
f‘1n(b^({k)(a)){ ‘1n, ({k)(b^({k)(a))g, ð7Þ
where ‘1n, ({k)(b) is the log-partial likelihood based on all
individuals not in =k. Finally, we find a^ that maximizes equation
(7). The numbers K~5 or K~10 are used commonly when n or p
is large [16,17,24]. Since the resultant estimators a^ and b^(a^) are
fairly robust against the choice of K in our simulations, we
recommend K~5 for computational simplicity.
Numerical Results
Evaluation Criteria
We first revisit the three measures for prediction accuracy
proposed by Bovelstad et al. [17]. Let f (ti, di, xi); i~1, . . . , n g
be a training dataset and b^ an estimator obtained from the training
dataset, and let f (ti , di , xi ); i~1, . . . , n g be a test dataset.
1) Log-rank test (LR-test): Subject i in the test dataset is categorized
in the good (poor) prognosis group if b^’xi is below (above) the
median of f b^’xi ; i~1, . . . , n g. The P-value for a log-rank test
performed in the test dataset for comparing survival times in the
two groups represents prediction performance. Smaller P-value
corresponds to better prediction ability.
2) Cox regression test (Cox-test): By treating gi~b^’x

i as a covariate,
the Cox model h(tDgi )~h0(t) exp (ag

i ) is fitted to
f (ti , di , gi ); i~1, . . . , n g. The P-value for testing the hypoth-
esis H0 : a~0 represents a measure of prediction ability. Smaller
P-value corresponds to better prediction ability.
3) Deviance (Devi): Let ‘n(b) be the log-partial likelihood function
calculated from the test dataset. The deviance{2f ‘n(b^){‘n(0) g
measures how the model with b~b^ improves the null model with
b~0 in terms of goodness-of-fit in the test dataset. Smaller
deviance corresponds to better prediction ability.
We further consider the c-index proposed by Harrell et al.
[25,26], which is a widely used measure for predictive accuracy for
censored survival data:
c{index~P
ivj
f I( tivtj )I( b^0x

iwb^
0x

j )dizI( t

jvti )I( b^
0x

jwb^
0x

i )dj gP
ivj
f I( tivtj )dizI( tjvti )dj g
,
Larger c-index corresponds to better prediction and c-
index= 0.5 means no prediction ability. The c-index is a less
subjective measure than the LR-test and Cox-test; it requires no
choice of a cut-off point for categorizing PI as in the LR-test, and
requires no model-fitting as in the Cox-test. The c-index is
Figure 1. The proposed shrinkage scheme applied for the
compound covariate method.
doi:10.1371/journal.pone.0047627.g001
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implemented in R (survConcordance routine in ‘‘survival’’
package) and other software [26].
Simulation Set-up
The objective is to compare the prediction ability of the
compound covariate method, the compound shrinkage method,
and other existing methods. Comparative studies of Bovelstad et
al. [17], van Wieringen et al. [18] and Bovelstad and Borgan [19]
all demonstrated that ridge regression has the overall best
predictive performance among many well-known survival predic-
tion methods, including the univariate selection, forward selection,
Lasso, principal components, supervised principal components,
partial least squares, random forests, etc. On the other hand, Gui
and Li [11], Segal [12] and Bovelstad and Borgan [19] still report
some cases in which the Lasso-type methods perform better.
Hence, we focus on the two benchmark methods of ridge
regression and Lasso as representatives of existing methods.
We set the p-dimensional regression parameter
b’~( b1, :::, bq, bqz1, :::, bp ) in the Cox model (1) with p = 100.
Note that we also considered p = 50 and 200 but obtained similar
results as reported in tables S1–1 , S1–4 in Supporting
Information S1. Consider a case, in which some of covariates
are related to survival time; the coefficients of the first q covariates
are nonzero and those of the remaining p - q covariates are zero.
We examined (I) sparse cases (q=2, 4, 5 or 10) and (II) less sparse
cases (q=10, 15, 20 or 30). Note that both the sparse and non-
sparse settings are plausible in biological problems [27]. For the
covariates x’~( x1, :::, xq, xqz1, :::, xp ), we adopt the following
random effects models to introduce correlations among the
covariates with a correlation coefficient equal to 0.5:
Scenario 1 (tag genes): Each of the q covariates is positively
correlated to s covariates that have zero coefficients. Specifically,
we set
xj~
Ajzuj
Akzuj
Uj
8><
>:
if
if
if
jƒ q ;
j~qz(k{1)sz1, :::, qzks, k~1, :::, q ;
j§qzqsz1
where Aj~U({0:75, 0:75), uj~U({0:75, 0:75),
Uj~U({1:5, 1:5), and they are independent of one another. This
scenario represents the setting that q independent sets of genes are
associated with survival; the (s +1) genes in each set are correlated,
and after accounting for one ‘‘tag gene’’ in each set of genes, the
other genes have no net effects on survival.
Scenario 2 (gene pathway): The q significant covariates are
positively correlated. We set
xj~
A1zuj
Uj
if
if
1ƒjƒq ;
qvjƒp ,

or
xj~
A1zuj
A2zuj
Uj
if
if
if
1ƒjƒq=2 ;
q=2vjƒq ;
qvjƒp ,
8><
>:
where Aj~U({0:75, 0:75), uj~U({0:75, 0:75),
Uj~U({1:5, 1:5), and they are independent of one another.
The former represents the setting that there exists a ‘‘gene
pathway’’ of q correlated genes that jointly affect survival, and the
latter does for two gene pathways of q/2 correlated genes. Hence,
scenario 2 represents a setting where the genes informative for
survival are correlated while scenario 1 represents a setting where
the informative genes are independent of each other.
For both scenarios, the covariates are standardized so that they
have standard deviation 1. The Cox model in (1) with h0(u)~1 is
chosen to generate survival times. Censoring times are generated
from U(0, 1), which yields moderate censoring (54,63%). We
first generate a training dataset of n~100 individuals, and
calculate b^, where b^ is the compound covariate, compound
shrinkage, ridge regression or Lasso estimator. K~5 cross-
validation is used to obtain the shrinkage parameters a for the
compound shrinkage estimator and l for ridge regression and
Lasso estimators. Ridge regression and Lasso analyses are
implemented through the R package ‘‘penalized’’ [21]. Then,
we generate the test dataset of size n~100, independently of the
training dataset, to calculate the prediction measures of LR-test,
Cox-test, Devi, and c-index.
In the subsequent simulations, we follow Bovelstad et al. [17] to
compare the values from the LR-test, Cox-test, Devi and c-index
by their median among 50 replications of training/test datasets.
Simulation results
The results for the sparse cases (q=2, 4, 5 or 10) are given in
Table 1. The Lasso generally works best in all prediction
measures. This pattern is only violated for the relatively large
number of significant covariates (q=10) where the compound
covariate or compound shrinkage method achieves better perfor-
mance in terms of the LR-test, Cox-test and c-index. Ridge
regression usually performs worst in terms of the LR-test, Cox-test,
and c-index. The compound shrinkage method is quite compa-
rable in the LR-test, Cox-test, and c-index to the compound
covariate method in all cases.
The four methods: CC = compound covariate, CS =
compound shrinkage, Ridge = ridge regression, and Lasso =
Lasso analyses are compared. The median values among the 50
replications for the LR-test (log10 P-value), Cox-test (log10 P-value),
Devi, c-index, and tuning parameters a^ or l^ are reported.
The results for the less sparse cases (q=10, 15, 20 or 30) are
given in Table 2. Unlike the sparse cases, the Lasso usually
performs worst in terms of the LR-test, Cox-test, and c-index,
especially in scenario 1 where the Lasso estimates often result in
the null model that has no prediction power (Devi = 0.000, c-
index= 0.501, 0.538). Overall, the comparative performance of
the compound covariate, compound shrinkage, and ridge regres-
sion methods are similar, but in scenario 2, the compound
covariate and compound shrinkage methods perform better than
the Lasso and ridge regression methods.
The four methods: CC = compound covariate, CS =
compound shrinkage, Ridge = ridge regression, and Lasso =
Lasso analyses are compared. The median values among the 50
replications for the LR-test (log10 P-value), Cox-test (log10 P-value),
Devi, c-index, and tuning parameters a^ or l^ are reported.
In terms of the Devi, ridge regression and Lasso methods have
much better performance than both the compound covariate and
compound shrinkage methods. In fact, the Devi may be unfair to
the proposed approach; the Devi measures a distance of b^ from the
benchmark value of b~0, and the majority of regression
coefficients obtained by ridge and Lasso are very close to or
exactly 0 by construction. In contrast, the compound covariate
and compound shrinkage methods have poorer performance in
the Devi because they are not shrunk to 0. However, poorer
Survival Prediction
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performance in the Devi is not carried over to other measures
based on association between the prognostic index and the survival
time, i.e., the LR-test, Cox-test, and c-index.
To see the robustness of the proposed method to the cross-
validation scheme, we perform the same set of simulations using
K~10 cross-validation in place of K~5. The results (not shown)
are virtually identical to these in Tables 1 and 2. Hence, the
performance of the compound shrinkage method is less affected by
the number of folds used in the cross-validation.
Although we found no single best method across all cases, the
comparative performance of the compound covariate and
compound shrinkage methods with other methods is remarkable.
Unlike ridge and Lasso analyses that may exhibit poor perfor-
mance in certain specific cases, the compound covariate and
compound shrinkage methods provide more stable performance
across different settings with sparse/non-sparse, independent/
correlated informative genes. This robustness property is desirable
in practical applications.
We perform similar simulations by increasing the magnitude of
non-zero coefficients. As reported in tables S1–5 and S1–6 in
Supporting Information S1, prediction performance improved for
all four methods, but the relative performances among them are
similar to those seen in Tables 1 and 2.
The Primary Biliary Cirrhosis Data Analysis
The primary biliary cirrhosis (PBC) data used in Tibshirani [10]
contains 276 patients with 17 covariates. Among them, 111
patients died while others were censored. The covariates consist of
a treatment indicator, age, sex, 5 categorical variables (ascites,
hepatomegaly, spider, edema, and stage of disease) and 9
continuous variables (bilirubin, cholesterol, albumin, urine copper,
alkarine, SGOT, triglycerides, platelet count, and prothrombine).
We use log-transformed continuous covariates to get stable results.
We compare the prediction performance over 50 random 2:1 splits
with 184 patients in the training set and 92 patients in the testing
set.
Table 3 reports the results for comparing the compound
covariate, compound shrinkage, multivariate Cox regression, ridge
regression and Lasso analyses. Multivariate Cox regression
analysis exhibits the worst performance, possibly due to a large
number of covariates. The other four methods that adapt to high-
dimensionality exhibit higher prediction power. Of these methods,
the compound covariate method performs best in terms of the LR-
test, Cox-test and c-index. This implies that the compound
covariate has the highest ability to discriminate between the poor
and good prognostic patients in the testing set. Notice that the
Table 1. Simulation results under sparse cases with p= 100 and n= 100 based on 50 replications.
b~ (1:5, 1:5, 0, :::, 0|ﬄﬄ{zﬄﬄ}
|98
), q=2 b~ (1, 1,{1,{1, 0, :::, 0|ﬄﬄ{zﬄﬄ}
|96
), q=4
CC CS Ridge Lasso CC CS Ridge Lasso
Scenario1, s= 4 LR-test 25.89 25.88 24.99 210.59 24.71 24.55 24.75 28.76
Cox-test 28.41 28.26 27.32 213.80 26.76 27.06 26.95 211.73
Devi 66.63 45.62 229.48 276.92 75.34 56.30 225.75 260.50
c-index 0.772 0.768 0.752 0.859 0.750 0.751 0.750 0.825
a^, l^ / 0.25 74.54 7.06 / 0.28 68.81 6.59
Scenario2 LR-test 28.88 29.35 27.01 212.39 26.38 26.74 26.30 211.40
Cox-test 212.16 212.35 29.64 214.51 29.27 29.94 28.77 214.21
Devi 217.25 226.02 243.04 295.39 24.63 211.32 236.79 284.14
c-index 0.828 0.833 0.790 0.879 0.785 0.790 0.770 0.864
a^, l^ / 0.30 37.88 6.90 / 0.30 50.91 6.17
b~ ( 0:8, :::, 0:8|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
|5
, 0, :::, 0|ﬄﬄ{zﬄﬄ}
|95
), q= 5 b~ ( 0:4, :::, 0:4|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
|5
, {0:4, ::: ,{ 0:4|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
|5
, 0, :::, 0|ﬄﬄ{zﬄﬄ}
|90
), q= 10
CC CS Ridge Lasso CC CS Ridge Lasso
Scenario1, s= 4 LR-test 23.88 24.31 24.21 26.64 22.28 22.45 22.40 21.90
Cox-test 26.18 26.19 26.04 29.47 23.03 23.03 23.01 22.86
Devi 80.59 56.87 221.44 243.22 145.95 97.88 29.28 27.85
c-index 0.725 0.722 0.722 0.790 0.659 0.656 0.652 0.649
a^, l^ / 0.28 79.85 6.89 / 0.275 101.77 8.44
Scenario2 LR-test 213.71 213.69 211.38 214.52 29.67 29.34 28.86 29.65
Cox-test 215.18 215.22 214.04 215.48 212.68 212.65 211.34 212.24
Devi 223.91 234.13 277.63 2107.14 8.563 20.559 255.62 267.93
c-index 0.886 0.885 0.862 0.889 0.843 0.835 0.822 0.838
a^, l^ / 0.33 33.34 6.66 / 0.29 47.22 6.86
NOTE: For Scenario 1, each informative covariate is correlated with s non-informative covariates. For Scenario 2, the covariates for the right panel have two gene
pathways and those for the left panel have one gene pathway. In each setting, q is the number of informative covariates (covariates with non-zero coefficients).
doi:10.1371/journal.pone.0047627.t001
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poor Devi value of the compound covariate method does not affect
its prediction power for patients’ prognosis.
NOTE: The median among the 50 replications for the LR-test
(log10 P-value), Cox-test (log10 P-value), Deviance, c-index, and
tuning parameters a^ or l^ are reported. Smaller values of the LR-
test, Cox-test and Deviance, and larger values of the c-index
correspond to more accurate prediction performance.
The five methods: CC = compound covariate, CS =
compound shrinkage, MultiCox = multivariate Cox regression,
Ridge = ridge regression, and Lasso = Lasso analyses are
compared.
The Lung Cancer Data Analysis
The non-small-cell lung cancer data of Chen et al. [6] is
available from http://www.ncbi.nlm.nih.gov/projects/geo/, with
accession number GSE4882. The data contains 672 gene profiles
for 125 lung cancer patients. Among them, 38 patients died while
others were censored. We use a subset consisting of 485 genes
whose coefficient of variation in expression values is greater than
3%. We divide the patients into 63:62 training/test datasets as in
Chen et al. [6]. Univariate Cox regression analysis based on the
training set identifies 16 genes that are significantly related to
survival (P-value ,0.05). Chen et al. [6] used the 16 regression
coefficients to classify the patients of the test dataset into good or
poor status. This 16-gene method is a compound covariate
analysis applied to the selected set of genes, though the compound
covariate method is applicable for the full sets of 485 genes. To
illustrate the compound covariate and the compound shrinkage
methods with high-dimensional covariates, we select p=97 genes
whose P-values of the univariate analysis are less than 0.20 in the
training dataset of n=63, and set the coefficients of remaining
genes to zero.
Table 2. Simulation results under less sparse cases with p= 100 and n= 100 based on 50 replications.
b~ ( 0:4, :::, 0:4|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
|10
, 0, :::, 0|ﬄﬄ{zﬄﬄ}
|90
), q=10 b~ ( 0:2, :::, 0:2|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
|10
, {0:2, :::,{0:2|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
|10
, 0, :::, 0|ﬄﬄ{zﬄﬄ}
|80
), q=20
CC CS Ridge Lasso CC CS Ridge Lasso
Scenario1, s= 2 LR-test 21.99 21.83 21.88 21.41 21.22 21.28 21.29 20.39
Cox-test 23.34 23.34 23.32 22.22 21.68 21.69 21.70 20.45
Devi 75.15 62.99 210.09 25.65 100.77 88.78 23.79 0.000
c-index 0.655 0.657 0.659 0.628 0.595 0.591 0.596 0.538
a^, l^ / 0.20 125.01 10.39 / 0.225 173.64 12.03
Scenario2 LR-test 215.80 214.84 213.71 214.80 210.35 29.49 29.33 29.11
Cox-test 215.35 215.30 215.05 215.57 213.23 212.98 212.30 212.01
Devi 59.54 48.07 292.79 2103.80 114.48 75.17 263.92 260.30
c-index 0.898 0.895 0.875 0.890 0.852 0.843 0.839 0.832
a^, l^ / 0.35 39.56 7.07 / 0.41 53.37 7.42
b~( 0:2, :::, 0:2|ﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄ}
|15
, 0, :::, 0|ﬄﬄﬄ{zﬄﬄﬄ}
|85
), q= 15 b~( 0:1, :::, 0:1|ﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄ}
|15
, {0:1, ::: ,{0:1|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
|15
, 0, :::, 0|ﬄﬄﬄ{zﬄﬄﬄ}
|70
), q= 30
CC CS Ridge Lasso CC CS Ridge Lasso
Scenario1, s= 2 LR-test 21.10 21.02 20.95 20.55 20.55 20.61 20.61 20.40
Cox-test 21.35 21.27 21.43 20.42 20.68 20.66 20.62 20.22
Devi 73.02 71.99 21.20 0.000 96.21 89.26 20.01 0.000
c-index 0.601 0.598 0.605 0.529 0.552 0.548 0.559 0.501
a^, l^ / 0.15 263.23 12.54 / 0.14 346.62 13.07
Scenario2 LR-test 212.27 211.84 211.40 211.41 27.93 26.80 26.67 26.05
Cox-test 212.87 212.82 212.77 212.73 210.55 29.83 29.65 28.79
Devi 291.82 177.76 274.42 271.46 326.63 141.46 246.02 238.22
c-index 0.873 0.865 0.854 0.850 0.810 0.790 0.794 0.778
a^, l^ / 0.45 60.36 8.33 / 0.53 84.43 8.42
NOTE: For Scenario 1, each informative covariate is correlated with s non-informative covariates. For Scenario 2, the covariates for the right panel have two gene
pathways and those for the left panel have one gene pathway. In each setting, q is the number of informative covariates (covariates with non-zero coefficients).
doi:10.1371/journal.pone.0047627.t002
Table 3. Performance of the five methods based on the
primary biliary cirrhosis of the liver data.
CC CS MultiCox Ridge Lasso
LR-test (log10 P-value) 27.95 27.00 26.35 26.98 27.11
Cox-test (log10 P-value) 212.49 211.18 210.71 210.89 210.71
c-index 0.846 0.829 0.825 0.843 0.834
Deviance 101.8 239.9 239.2 249.4 245.9
a^ (CS), l^ (Ridge/Lasso) / 0.875 / 22.75 7.32
doi:10.1371/journal.pone.0047627.t003
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We compare the compound covariate, compound shrinkage,
ridge regression, and Lasso methods as well as the 16-gene
compound covariate method of Chen et al. [6]. The results are
summarized in Table 4. In terms of the LR-test, the compound
covariate method performs best, while, in terms of the Cox-test
and c-index, the compound shrinkage method performs best.
Figure 2 shows that the two survival curves for the good and poor
prognosis groups are best separated by the compound covariate
method. However, Figure 3 shows that the Kaplan-Meier curves
for the good, medium and poor prognosis groups cross one
another and are less distinguishable by the compound covariate
method. Here the good, medium, and poor groups are determined
by the tertiles of the PI’s in the test datasets. On the other hand,
the three Kaplan-Meier curves are well-distinguished in the
compound shrinkage method, as implied by its best performance
in the Cox-test and c-index (Figure 3; Table 4). This analysis
suggests that, compared to the compound covariate method, the
compound shrinkage method may provide more accurate ranking
of patients’ risks with respect to their survival status. Although
ridge regression and Lasso has much smaller deviance, it has
poorer performance in the LR-test, Cox-test and c-index.
To see the robustness of the conclusion, comparison of the
methods is made under various different numbers of genes,
including p~124 genes whose P-values of the univariate analysis
are less than 0.25. As seen from the Supporting Information S2,
the compound covariate method still performs best in terms of the
LR-test. However, the compound shrinkage method still has the
best performance in the Cox-test and c-index, and it provides the
best separation among the survival curves for the good, medium,
and poor prognosis groups. In fact, the compound shrinkage
method almost always has the best c-index values under varying
number of genes passing a univariate pre-filter for inclusion in the
PI (Figure 4). Hence, the conclusion is unchanged.
We also compared the computation time of the four methods in
Table 4. The compound covariate method achieves the fastest
computation time since it merely repeats p=97 univariate Cox
regressions using the R ‘‘coxph’’ routine. Ridge regression requires
about 5 times and Lasso has about 7 times longer computation
time than the compound covariate method. The compound
shrinkage is decidedly the slowest, due to the cost of finding high-
dimensional maxima b^(a^) and b^({k)(a).
Analytical Results
Large Sample Results for the Shrinkage Method
The first analytical result of the compound shrinkage method is
the large sample consistency of the survival prediction. That is, as
n?? with fixed p, the estimated shrinkage parameter a^ tends to 1
and the compound shrinkage estimator b^(a^) tends to the true
parameter value b0. The second and more practically important
result is a formula for the standard deviation of b^(a^) that may be
useful for calculating P-values for each covariate.
To describe the analytical properties of a^ and b^(a^), define, for
k~0, 1, 2,
S(k)(b; t)~
Xn
i~1
Yi(t)x
k
i exp (b’xi), s
(k)(b; t)~Ef S(k)(b; t)=n g,
where x0i:1, x
1
i:xi, x
2
i:xix’i and Yi(t)~I(ti§t) with I(:)
being an indicator function, and for j~1, :::, p,
S
(k)
j (bj ; t)~
Xn
i~1
Yi(t)x
k
ij exp (bjxij), s
(k)
j (bj ; t)~Ef S(k)j (bj ; t)=n g,
E(b; t)~S(1)(b; t)=S(0)(b; t), e(b; t)~s(1)(b; t)=s(0)(b; t),
Ej(bj ; t)~S
(1)
j (bj ; t)=S
(0)
j (bj ; t), ej(bj ; t)~s
(1)
j (bj ; t)=s
(0)
j (bj ; t),
V(b; t)~S(2)(b; t)=S(0)(b; t){E(b; t)E(b; t)’,
Vj(bj ; t)~S
(2)
j (bj ; t)=S
(0)
j (bj ; t){Ej(bj ; t)
2:
The score function defined as the derivative of ‘an(b) with respect
to b is given by
Uan(b)~
Xn
i~1
dif xi{aE(b; ti){(1{a)( E1(b1; ti), :::,Ep(bp; ti) )’g:
The observed Fisher information matrix, the negative of the
Hessian of ‘an(b), is
Van(b)~
Xn
i~1
dif aV(b; ti)z(1{a)diag(V1(b1; ti), :::, Vp(bp; ti) )g,
where diag( V1(b1; ti), :::, Vp(bp; ti) ) is the diagonal matrix
with the diagonal element ( V1(b1; ti), :::, Vp(bp; ti) ). It is easy
to verify that Van(b) is positive semi-definite and hence ‘
a
n(b) is
Table 4. Performance of the five methods based on the non-
small-cell lung cancer data of Chen et al. [6].
97 genes 16 genes
CC CS Ridge Lasso CC
LR-test (log10
P-value)
21.12 20.75 20.04 20.15 20.84*
Cox-test (log10
P-value)
20.19 20.78 20.03 20.12 20.16
c-index 0.581 0.606 0.535 0.544 0.584
Deviance 1520.3 68.4 15.2 15.8 439.5
a^ (CS), l^ (Ridge/Lasso) / 0.70 11.58 2.66 /
Computation time
(sec)
0.41 895.9 2.12 3.05 0.06
NOTE: Smaller values of the LR-test (log10 P-value), Cox-test (log10 P-value) and
Deviance, and larger values of the c-index correspond to more accurate
prediction performance.
*If good and poor groups are separated by the median PI in the training set, the
LR-test has P-value = 0.034 (log10 P-value =21.47) with n= 28 in the good and
n= 34 in the poor groups (the same result as Figure 1C of Chen et al. [6]).
The methods: CC = compound covariate (using 97 or 16 genes), CS =
compound shrinkage, Ridge = ridge regression, and Lasso = Lasso analyses
are compared.
doi:10.1371/journal.pone.0047627.t004
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concave for a given a[½0, 1. For a[½0, 1), Van(b) is typically
positive definite and ‘an(b) is strictly concave, which implies that
b^(a) is unique even when pwn.
Now we state the large sample results as n?? with fixed p; the
proofs are given in Supporting Information S3. Assume that
f (ti, di, xi); i~1, . . . , n g are independently and identically
distributed under the model (1) with b~b0, and a[½0, 1 is a fixed
constant. Applying martingale calculus and the concave property
of ‘an(b) under mild regularity conditions (e.g. p.497–498 of [28]),
we verify that b^(a) converges in probability to b(a), a solution to a
h(a, b)~0 for a given a[½0, 1 where
h(a, b)~
ð?
0
s(1)(b0; u)h0(u)du{
ð?
0
ea(b; u) s(0)(b0; u)h0(u)du, ð8Þ
where ea(b; u)~ae(b; u)z(1{a)( e1(b1; u), :::, ep(bp; u) )’:
Note that, for a~0, equation (8) is a multivariate generalization
of equation (2–5) of Struthers and Kalbfleish [29] in the context of
the misspecified Cox regression analysis. For a~1, the solution to
h(1, b)~0 is b0, and hence b
(1)~b0.
Proposition 1 (Consistency): As n??, a^ converges in probability to
1. Also, b^(a^) converges in probability to b0.
Proposition 2 (Asymptotic normality): As n??,
ﬃﬃﬃ
n
p
( a^{1 )
converges weakly to a mean zero normal distribution with
variance vCV (b0). Also,
ﬃﬃﬃ
n
p
( b^(a^){b0 ) converges weakly to a
mean zero normal distribution with covariance matrix S(b0).
Explicit formulas for vCV (b0) and S(b0) are derived in Supporting
Information S3.
Remark I. We allow a^w1 when CV (a) is maximized at aw1.
Remark II. The asymptotic variance S( b0 ) can be consistently
estimated by Sa^n( b^(a^) ), where
Figure 2. Kaplan-Meier curves for the 62 patients in the lung cancer data of Chen et al. [6]. Good (blue) and poor (red) groups are
determined by the median of the PI’s in the test dataset.
doi:10.1371/journal.pone.0047627.g002
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San( b )~A
a
n( b )
Van( b )
n
 {1
Aan( b )’,
Aan( b )~
Van( b )
{1 _hn( b ) _hn( b )’
{d2CV (a)=da2
zIp,
_hn( b )~
LUan( b )
La
~
Xn
i~1
dif{E(b; ti)z( E1(b1; ti), :::, Ep(bp; ti) )0 g,
where Ip is the unit matrix of size p. The estimator S
a^
n( b^(a^) )
gives reasonable approximation to the variance of b^(a^) even when
p is large (see simulations for p=100 and n=100 in Supporting
Information S3). The variance estimate facilitates the Wald-type
test for significance of the regression coefficients.
Analytical Comparison with the Lasso and Ridge
Regression
Unlike the Lasso and ridge regression in equations (3) and (4),
which shrink the regression coefficients toward 0~( 0, :::, 0 )’, the
compound shrinkage estimator is obtained by shrinking the
coefficients toward the compound covariate estimator
b^(0)~( b^1(0), :::, b^p(0) )’.
We apply a statistical large sample theory on the misspecified
Cox regression analysis [29,30] to demonstrate that shrinking the
regression coefficients toward the compound covariate estimator
may be more informative than shrinking toward 0 when covariates
are independent. When n goes to infinity, the compound covariate
estimator b^(0) converges in probability to a vector
b(0)~( b1(0), :::, b

p(0) )’, a solution to h(0, b)~0 that is defined
in equation (8). In general, b(0)=b0, where b0~( b01, :::, b0p )’ is
the true parameter value in equation (1). Nevertheless, b(0)
contains information about b0. Without loss of generality, we will
describe the properties of the first component b1(0) of b
(0), where
Figure 3. Kaplan-Meier curves for the 62 patients in the lung cancer data of Chen et al. [6]. Good (blue), medium (black), and poor (red)
groups are determined by the tertile of the PI’s in the test dataset.
doi:10.1371/journal.pone.0047627.g003
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the censoring is assumed independent of survival time and
covariates.
(P1) If b02~   ~b0p~0, then b1(0)~b01.
(P2) Suppose that xi1 and (xi2, :::, xip) are independent for all
i (~1, . . . , n). If b01~0, then b

1(0)~0. If b01=0, then
0vb1(0)vb01 when 0vb01, or b01vb

1(0)v0 when b01v0.
The property (P1) is due to the fact that the univariate Cox
estimate b^1(0) is obtained under the assumption that the hazard
given xi1 is of the form h01(t) exp (b1xi1), which is true when
b02~   ~b0p~0 under equation (1). An important implication
from the property (P1) is that, if b0~0, then b
(0)~0 as well. The
property (P2) is deduced from some known results of misspecified
Cox regression analysis [29,30]. The property (P2) implies that, if
all the covariates are independent, the sign of each component of
b(0) agrees with that of b0, and b
(0) is closer to b0 than 0. From
the above properties, it is then expected that shrinking the
regression coefficients toward b(0) may be more informative than
shrinking them toward 0. This gives an analytical reason justifying
the proposed shrinkage method. The justification in the presence
of correlations among covariates is analytically intractable, and
hence is done by simulations and real data analysis as presented
above.
The proposed shrinkage method has a natural interpretation
under a setting of linear regression. Let y~( y1, :::, yn )’ be the
response vector and X’~( x1, :::, xn ) be the design matrix, where
xi~( xi1, :::, xip )’ is the covariate for individual i. In the ordinary
least square regression, we minimize the objective functionPn
i~1 ( yi{b’xi )
2. If pwn, it does not have a unique minimizer
since the design matrix X’X is singular. The proposed shrinkage
scheme leads to minimizing.
a
Xn
i~1
( yi{b’xi )
2z(1{a)
Xn
i~1
Xp
j~1
( yi{bjxij )
2,
for some a[½0, 1). The minimizer of the above function is
unique and written as
b^Shrink(a)~ aX’Xz(1{a )diag(X’X)½ {1X’y
where diag(X’X) is a diagonal matrix with the same diagonal
elements as in X’X. The singularity of X’X is thus resolved by
reducing the off-diagonal values by a multiplicative factor a. This is
in contrast to ridge regression [13] where the diagonal values are
increased by an additive factor lw0, that is,
b^Ridge(l)~½ X’Xzl Ip {1X’y:
Figure 4. The c-index assessments of the four methods under varying number of top genes (p=16, 124 ) in the lung cancer data of
Chen et al. [6], where ‘‘top genes’’ refer to most strongly associated genes passing a univariate pre-filter for inclusion in the linear
predictor (PI).
doi:10.1371/journal.pone.0047627.g004
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With complete shrinkage, the difference between the two
estimators becomes evident since b^Shrink(0)~f diag(X’X) g{1X’y
while b^Ridge(?)~0.
Computing Algorithms
Numerical maximization of ‘an(b) in equation (6) can be done
through quasi-Newton type algorithms. For instance, the R ‘‘nlm’’
is a reliable routine to find the minimum of{‘an(b) with a large p.
Numerical maximization of CV (a) in equation (7) can be
obtained by a grid search on finely selected values of a as
commonly done in cross-validation [17,24]. In our numerical
studies we observe that the graph of CV (a) is always unimodal,
and calculating CV (a) with smaller a is always faster than with
larger a. Utilizing these properties, we suggest the following
computation algorithm, which is more efficient in computation
than the ‘‘exhaustive search’’ procedure:
Step 1: Set a~0 and a positive number Da (e.g., Da~0:025),
and calculate CV (0).
Step 2: Set a~azDa. If a§1, then go to Step 3. If
CV (a)ƒCV (a), then go to Step 3. If CV (a)wCV (a), then
set a~a and return to Step 2.
Step 3: Stop the algorithm and set a^~a.
Conclusions
We have revisited a compound covariate prediction method for
predicting survival outcomes with a large number of covariates.
This method is popularly employed in medical studies, but its
statistical performance has been less studied in the literature. We
investigate the prediction power of the method by comparison
with the well-known methods of ridge regression and Lasso, both
of which adapt to a large number of covariates. The simulations
demonstrate that the compound covariate method has better
predictive power than ridge regression when only a few among a
large number of covariates associate with the survival (i.e., sparse
cases), and that it performs better than the Lasso when many of a
large number of covariates simultaneously affect the survival (i.e.,
less sparse cases). The compound covariate method exhibits best
predictive power among all the competitors in the primary biliary
cirrhosis dataset, including the multivariate Cox regression, ridge
regression and Lasso. In the even much higher dimensional lung
cancer microarray data, where the multivariate Cox regression no
longer applies, the compound covariate method similarly outper-
forms ridge regression and Lasso. Hence, the compound covariate
method is a computationally attractive and powerful technique for
survival prediction with a moderate or large number of covariates.
To further improve the prediction power of the compound
covariate prediction, we propose a novel shrinkage type estimator
for survival prediction with a large number of covariates. The new
shrinkage scheme refines the compound covariate method by
incorporating the multivariate likelihood information into the
compound covariate predictor. Our simulation studies demon-
strate that, in the sparse signal setting, the Lasso strongly
outperforms the ‘‘non-sparse’’ methods, including ridge regression,
compound covariate and compound shrinkage methods. On the
other hand, in settings with less sparse signals, the compound
covariate and compound shrinkage methods perform comparably
to ridge regression, and all these methods outperform the Lasso
method. Given that the non-sparse setting is not uncommon [27],
and ridge regression shows best overall performance in several
comparative prediction studies [17,18,19], the compound covar-
iate and compound shrinkage methods have the potential to be
useful alternatives. Our proposal also provides a novel framework
of shrinkage estimation that encompasses the simple but effective
compound covariate method as a special case. In the lung cancer
data analysis we find that, the major advantage of the proposed
compound shrinkage method over the compound covariate
method is in its more accurate prediction of patient’s survival
status. We also establish statistical large sample theories, including
consistency and standard error estimation of the parameter
estimator, for the proposed shrinkage method. Given these
numerical and theoretical evidences, the proposed prediction
scheme seems to be a method that can be reliably applied for
survival prediction. The method is implemented by an R package
‘‘compound.Cox’’ available in CRAN at http://cran.r-project.
org/.
A potential extension of the proposed shrinkage method is the
development of covariate selection. This is clearly an important
issue in microarrays in which the focus is to select genes that
achieve good predictive power. If the gene selection is the main
focus, we find the Lasso method offers an elegant solution since it
gives an automatic way of selecting genes. In fact, the Lasso shows
excellent performance when the signal is sparse, as shown in our
simulation studies (Table 1). However, in the presence of a large
number of informative genes (less sparse cases), the performance of
the Lasso is less reliable since it tends to select only a few genes
among them and often results in the null model with no prediction
power (Table 2). A large number of informative genes are also
encountered in the lymphoma data reported in Matsui [16], where
the number of genes in the optimal set is t=75 or 85. Matusi [16]
suggests a gene filtering procedure that chooses the top t genes in
terms of univariate Cox analyses, where t is the threshold that
leads to the best predictive power in cross validation. Although this
methodology is computationally simple, the top t genes are based
on univariate significance only. Hence, it is interesting to extend
the gene filtering approach to take into account the combined,
multivariate predictive information of genes using the proposed
shrinkage method. We will leave this problem to a future research
topic.
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